XTalks

MAY 9, 2024

XTALKS CLINICAL EDGE: Issue 2 — Genmab’s Interview Xtalks Clinical Edge is a magazine for clinical research professionals and all who want to be informed about the latest trends and happenings in clinical trials. Celebrating 25 years of innovation is a significant milestone.

Antibody 52

Antibody Clinical Trials Clinical Trials Medicine 52

Drug Discovery World

DECEMBER 27, 2023

Ng is working on critical challenges in clinical trials, specifically in planning and recruitment, and has been building innovative solutions designed to benefit patients and researchers – with a focus on efficiency, transparency and diversity in clinical development. Listen here. Listen here.

Clinical Trials 69

Clinical Trials Clinical Trials Drugs Development 69

pharmaphorum

MAY 25, 2021

Dr Ignacio Medrano, chief medical officer and founder at Savana, said: “We are now able to teach a computer how to read records and turn free text into a database of clinical variables.”. Data collected like this is also acceptable to regulators, pointed out Medrano, meaning that it can be used during the clinical development process.

Big Data 134

Big Data Clinical Research Research Trials 134

The Pharma Data

OCTOBER 25, 2020

BTI’s drug re-innovation approach leverages existing approved drugs and/or clinically evaluated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices.

Trials 52

Trials Production FDA Approval Development 52

XTalks

AUGUST 2, 2023

With Blackstone Life Sciences, up to €300 million (around $315 million USD) will be invested to accelerate pivotal studies and clinical development programs for formulating the subcutaneous delivery of the anti-CD38 antibody Sarclisa (isatuximab) for the treatment of multiple myeloma. billion ($3.65 billion ($2.85 billion in 2022.

Sales 98

Sales Manufacturing FDA Approval Life Science 98